Gerresheimer's Creditors Deliver a Lifeline, But Legal and Accounting Woes Deepen

German packaging firm Gerresheimer secures crucial debt extension to 2026 after accounting scandal, sparking an 18% stock surge but major challenges remain.

A staggering 96% approval rate from its creditors has thrown German packaging specialist Gerresheimer a crucial financial lifeline. The agreement, covering €870 million in debt, grants the company a critical extension until September 30, 2026, to file its audited 2025 financial statements. In a parallel move, banking partners have agreed to the same deadline and suspended key leverage covenants until the end of the third quarter of 2026. The market's immediate reaction was a surge of relief, propelling the share price up by 18% in a single session last Thursday.

Despite this week's powerful rally, the underlying picture remains fraught with peril. The company's stock, which closed Friday at €21.40—marking a weekly gain of nearly 25%—still languishes roughly two-thirds below its 52-week high of €64.40. This technical rebound follows a painful deranking from the SDAX index in mid-April, which forced index-tracking funds to sell, compounding a year-to-date loss of approximately 23%.

The core of Gerresheimer's crisis stems from systematic accounting errors. An independent law firm confirmed the company improperly booked revenue from so-called "bill-and-hold" agreements, where goods are invoiced before delivery, in clear violation of IFRS rules. The financial misstatement is substantial, involving €35 million in incorrectly recognized 2024 revenue and a €24 million correction to operating profit (EBITDA). Furthermore, planned impairment charges are estimated between €220 million and €240 million.

Legal scrutiny is intensifying behind the scenes. Germany's audit oversight body, APAS, has initiated professional misconduct proceedings against auditor KPMG. The probe focuses on KPMG issuing an unqualified audit opinion for 2024 shortly after taking over the mandate, despite the now-confirmed accounting irregularities. Simultaneously, the German shareholder association DSW is examining potential damage claims against the company's former management.

To repair its strained balance sheet, Gerresheimer is aggressively pursuing the sale of its US subsidiary, Centor Inc. The process, managed by Morgan Stanley, has attracted a double-digit number of interested parties. Centor is carried on the books at €292 million, and management anticipates a deal could be finalized within the current year, providing a potential capital boost.

The company aims to submit its audited 2025 financials by June 2026, two months ahead of the creditor-agreed deadline. Achieving this would remove a significant overhang. For now, the business reports operational performance in line with expectations and a solid order book. All eyes are now on the next hard deadline: the half-year report due on July 14, 2026. Whether this week's surge is a sustainable recovery or a temporary respite hinges on the company's ability to navigate its legal quagmire and successfully execute its financial stabilization plan.